A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010–2016
Crossref DOI link: https://doi.org/10.1007/s40273-016-0458-0
Published Online: 2016-10-31
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McRae, Jacquelyn
Vogenberg, F. Randy
Beaty, Silky Webb
Mearns, Elizabeth
Varga, Stefan
Pizzi, Laura
License valid from 2016-10-31